Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone disorders, androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely acidifiers to increase levels of gastric acid to decrease stomach pH for human purposes; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids, leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use.

Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone disorders, androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely acidifiers to increase levels of gastric acid to decrease stomach pH for human purposes; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use.

Chemicals and chemical preparations for use in preparing, protecting, lubricating, cleaning, coating, and sealing molds, tooling equipment, and process equipment; mold release preparations; mold release compounds for use in a wide variety of industries; mold release agents; mold release preparations for use on casting molds and forming molds and tooling; protective coatings for use in manufacturing and industrial applications; protective coatings for use on molded parts, molds, casting molds, and forming molds; rust preventatives in the nature of coatings; protective coatings and preparations, namely, coating preparations, anti-corrosive coatings, corrosion inhibiting preparations, and mold storage preparations for use on molds, casting molds and forming molds; anti-corrosive coatings and preparations, namely, coating preparations; cleaning preparations for use on molds, casting molds and forming molds in industry; cleaning preparations for use in industry; cleaning preparations for molds; cleaning preparations for machinery, equipment, and parts thereof used in casting and forming; lubricants for use in the casting and forming industries; industrial lubricants; lubricating release agents, namely, lubricants for facilitating the release of items from molds and castings and for use on molds, casting molds and forming molds; lubricants for machines and tooling used in the molding, casting and forming process

Mold release agents for general industrial use

Chemical additives including chloroform, chlorobenzene, dichloromethane, dichloroethane, tetrachloroethanem, acetone, dioxane, ethyl acetate, methyl ethyl ketone, isopropanol, anisole, n-menthylpyrrolidone (nmp), n,n-dimethylformamide (dmf), ethanol, tetrahydrofuran (thf), toluene, xylene, halogenated organic solvents. organic solvents, water, epoxy, and polyurethane or polyurea, all unprocessed for use in the commercial manufacture of nanotubes; enhanced materials comprising epoxy resins, polyurea pre-polymers, or polyurethane pre-polymers, all unprocessed for use in the commercial manufacture of nanotubes, nanoparticles, carbon or boron nitride fibers, carbon or boron nitride ropes, carbon or boron nitride ribbons, carbon or boron nitride fibrils, carbon or boron nitride needles, graphite platelets, nanodots, and other fullerene materials; chemical preparations for use with commercial polymers for use by third parties in their manufacture or production of a wide variety of goods; processed, functionalized, or enhanced nanotubes, nanoparticles, carbon or boron nitride fibers, carbon or boron nitride ropes, carbon or boron nitride ribbons, carbon or boron nitride fibrils, carbon or boron nitride needles, graphite platelets, nanodots.

Microassembly systems, mesoscale systems, nanoassembly systems, and macroassembly systems, namely systems for manufacture of microscale, mesoscale, and nanoscale component, nanomanipulator prober, miniature electron optical bench platform for electron and ion optic applications, miniature ion trap mass spectrometer, microscale motors, fiber aligner, e-beam current analysis system, low noise characterization system, mesoscale positioning system, microgripper and nanoscale probers; laboratory robots for grasping, rotating, moving and assembling microscale and nanoscale components for microelectromechanical systems fabrication and assembly; laboratory robots for use in the field of nanotechnology; microscale assemblers, nanoscale assemblers, mesoscale assemblers, and macroscale assemblers for use in the field of nanotechnology; nanomanipulators; nanotechnology research tools, namely systems for manufacture of microscale, mesoscale, and nanoscale component, nanomanipulator prober, miniature electron optical bench platform for electron and ion optic applications, miniature ion trap mass spectrometer, microscale motors, fiber aligner, e-beam current analysis system, low noise characterization system, mesoscale positioning system, microgripper and nanoscale probers and nanotechnology equipment and attachments to same for manipulation and/or characterization of nanotechnology materials; grippers, clamps, micromechanical probes, nanomechnical probes, probes, actuators, positioners, drivers and related attachments and tools for microscopes and nanomanipulators; instrumentation software used for cleaning and reducing contamination in Scanning Electron Micorscope (SEM) vacuum chambers, and focused Ion Beam Unit vacuum chambers, and other controlled environment chambers, namely vacuum chambers, high pressure chambers and glove boxes used in the fields of materials science, metrology, microscale research and nanoscale research; software for molecular modeling, computer aided design, and computer aided manufacturing in the field of nanotechnology.

Chemical additives including chloroform, chlorobenzene, dichloromethane, dichloroethane, tetrachloroethanem, acetone, dioxane, ethyl acetate, methyl ethyl ketone, isopropanol, anisole, n-menthylpyrrolidone (nmp), n,n-dimethylformamide (dmf), ethanol, tetrahydrofuran (thf), toluene, xylene, halogenated organic solvents. organic solvents, water, epoxy, and polyurethane or polyurea, all unprocessed for use in the commercial manufacture of nanotubes; enhanced materials comprising epoxy resins, polyurea pre-polymers, or polyurethane pre-polymers, all unprocessed for use in the commercial manufacture of nanotubes, nanoparticles, carbon or boron nitride fibers, carbon or boron nitride ropes, carbon or boron nitride ribbons, carbon or boron nitride fibrils, carbon or boron nitride needles, graphite platelets, nanodots, and other fullerene materials; chemical preparations for use with commercial polymers for use by third parties in their manufacture or production of a wide variety of goods; processed, functionalized, or enhanced nanotubes, nanoparticles, carbon or boron nitride fibers, carbon or boron nitride ropes, carbon or boron nitride ribbons, carbon or boron nitride fibrils, carbon or boron nitride needles, graphite platelets, nanodots.

Microassembly systems, mesoscale systems, nanoassembly systems, and macroassembly systems, namely systems for manufacture of microscale, mesoscale, and nanoscale component, nanomanipulator prober, miniature electron optical bench platform for electron and ion optic applications, miniature ion trap mass spectrometer, microscale motors, fiber aligner, e-beam current analysis system, low noise characterization system, mesoscale positioning system, microgripper and nanoscale probers; laboratory robots for grasping, rotating, moving and assembling microscale and nanoscale components for microelectromechanical systems fabrication and assembly; laboratory robots for use in the field of nanotechnology; microscale assemblers, nanoscale assemblers, mesoscale assemblers, and macroscale assemblers for use in the field of nanotechnology; nanomanipulators; nanotechnology research tools, namely systems for manufacture of microscale, mesoscale, and nanoscale component, nanomanipulator prober, miniature electron optical bench platform for electron and ion optic applications, miniature ion trap mass spectrometer, microscale motors, fiber aligner, e-beam current analysis system, low noise characterization system, mesoscale positioning system, microgripper and nanoscale probers and nanotechnology equipment and attachments to same for manipulation and/or characterization of nanotechnology materials; grippers, clamps, micromechanical probes, nanomechnical probes, probes, actuators, positioners, drivers and related attachments and tools for microscopes and nanomanipulators; instrumentation software used for cleaning and reducing contamination in Scanning Electron Micorscope (SEM) vacuum chambers, and focused Ion Beam Unit vacuum chambers, and other controlled environment chambers, namely vacuum chambers, high pressure chambers and glove boxes used in the fields of materials science, metrology, microscale research and nanoscale research; software for molecular modeling, computer aided design, and computer aided manufacturing in the field of nanotechnology.

Pharmaceutical preparations and substances namely antibiotics for human use; plasters; material for stopping teeth, dental wax; preparations for destroying vermin; fungicides, herbicides.

Pharmaceutical preparations and substances namely antibiotics for human use; plasters; material for stopping teeth, dental wax; preparations for destroying vermin; fungicides, herbicides.

Antibiotics for human use.

Pharmaceutical preparations and substances namely antibiotics for human use; plasters; material for stopping teeth, dental wax; preparations for destroying vermin; fungicides, herbicides.

Pharmaceutical preparations and substances, namely antibiotic preparations for the treatment of patients with serious infections, namely pneumonia, bacteremia and skin infections.